Regeneron completes acquisition of Sanofi’s stake in Libtayo

Regeneron completes acquisition of Sanofi’s stake in Libtayo

Source: 
Pharmaceutical Business Review
snippet: 


Regeneron Pharmaceuticals has completed the purchase of Sanofi's stake in cancer drug Libtayo (cemiplimab).